Comparison of real-world outcomes in patients with nonvalvular atrial fibrillation treated with direct oral anticoagulant agents or warfarin
Author:
Affiliation:
1. Comprehensive Health Insights, Humana Inc., Louisville, KY
2. Janssen Scientific Affairs, Janssen Pharmaceuticals, Titusville, NJ
3. Humana Inc., Louisville, KY
Publisher
Oxford University Press (OUP)
Subject
Health Policy,Pharmacology
Link
http://academic.oup.com/ajhp/article-pdf/76/5/275/28791505/zxy032.pdf
Reference35 articles.
1. AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society;January;Circulation,2014
2. Atrial fibrillation and cause‐specific risks of pulmonary embolism and ischemic stroke;Hald;J Am Heart Assoc.,2018
3. Trends in utilization of warfarin and direct oral anticoagulants in older adult patients with atrial fibrillation;Alalwan;Am J Health-Syst Pharm.,2017
4. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation;Patel;N Engl J Med.,2011
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Patients on vitamin K treatment: is switching to direct-acting oral anticoagulation cost-effective? A target trial on a prospective cohort;Open Heart;2024-01
2. Frailty, Home Time, and Health Care Costs in Older Adults With Atrial Fibrillation Receiving Oral Anticoagulants;JAMA Network Open;2023-11-09
3. Mortality on DOACs Versus on Vitamin K Antagonists in Atrial Fibrillation: Analysis of the Hungarian Health Insurance Fund Database;Clinical Therapeutics;2023-04
4. Adherence and Quality of Life in Non-Valvular Atrial Fibrillation With Direct Oral Anticoagulants Versus Vitamin K Antagonists: A Systematic Review;International Journal of Cardiovascular Sciences;2023
5. Dose specific effectiveness and safety of DOACs in patients with non-valvular atrial fibrillation: A Canadian retrospective cohort study;Thrombosis Research;2021-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3